Collplant Biotechnologies Ltd Capital Reinvestment Ratio
Collplant Biotechnologies Ltd capital reinvestment ratio. Collplant Biotechnologies Ltd (CLGN) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow ($6.78 Million) in capital expenditures ($243.00K). Check total reinvestment intensity of Collplant Biotechnologies Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Collplant Biotechnologies Ltd (2021–2021)
Capital reinvestment ratio of Collplant Biotechnologies Ltd from 2021 to 2021. This chart tracks Collplant Biotechnologies Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Collplant Biotechnologies Ltd (CLGN) net asset momentum to track the company's year-over-year net asset growth rate.
Collplant Biotechnologies Ltd Capital Reinvestment Ratio by Year (2021–2021)
Collplant Biotechnologies Ltd capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see cash efficiency ratio of Collplant Biotechnologies Ltd.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.57x | $2.50 Million | $1.43 Million | — |